Baudax Bio
BXRX
$0.02180
Share price
7.39%
Change (1 day)
-97.13%
Change (1 year)
Categories
Baudax Bio (BXRX) - Cash on Hand
Cash on Hand as of September 2023 : $0.36 M
According to Baudax Bio
's latest financial reports the company has $0.36 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Baudax Bio - Cash on Hand chart (from 2018 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $5.25 M | -66.91% |
| 2021-12-31 | $15.89 M | -47.63% |
| 2020-12-31 | $30.34 M | 71.04% |
| 2019-12-31 | $17.74 M | |
| 2018-12-31 | $N/A |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 57,251.79% | 🇺🇸 USA |